Engflag

EludrilPro

Quick links to important sections

EludrilPro

EludrilPro_PL

Method of action: Disinfectant

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of EludrilPro

Quick Facts

Property Description
Active Ingredients Chlorhexidine Gluconate, Chlorobutanol
Form Oral Solution (Mouthwash)
Pharmacological Class Oromucosal Antiseptic, Dental Anti-infective Agent
Common Use High-level oral hygiene maintenance and localized relief
Origin Synthetic Combination Product

What Type of Medicine is EludrilPro?

EludrilPro is a combination pharmaceutical preparation chemically classified as an Oromucosal Antiseptic and Dental Anti-infective Agent. The dosage form is an Oral Solution or mouthwash, specifically designed for local application to the oral cavity and throat surfaces (oromucosal route of administration). This preparation is a therapeutic agent, distinguishing it from non-medicated, general-purpose oral hygiene rinses.

The primary active component, Chlorhexidine Gluconate, is a potent anti-infective agent derived from the biguanide chemical family. This classification reflects its defined purpose of providing high-level surface cleansing and managing the microbial environment within the mouth.

Composition and Dual-Action Active Ingredients

The solution is a combination product that features two core active pharmaceutical ingredients: Chlorhexidine Gluconate and Chlorobutanol. The preparation is synthetic in origin, dissolved in an aqueous-alcoholic base. Chlorhexidine is responsible for the powerful antiseptic properties, an action involving microbial cell membrane disruption.

The distinctive inclusion of Chlorobutanol serves as a bacteriostatic agent and also exhibits weak local anesthetic actions. This dual-action formulation is a differentiating factor, aiming to provide comprehensive support by combining established antiseptic action with localized pain mitigation.

General Purpose and Benefit

The general purpose of EludrilPro is to aid in high-level oral hygiene maintenance by controlling oral microorganisms and providing temporary, localized mitigation of discomfort. A key property of Chlorhexidine is its substantivity, meaning it binds to oral tissues and is slowly released over time, extending its antimicrobial activity beyond the immediate rinse. This means the medicine provides a prolonged protective effect for the oral surfaces after application, a feature particularly valuable for supporting comfort and cleanliness in the oral environment.

What side effects are possible with EludrilPro?

Possible Side Effects and Safety Information

The safety profile for this oral solution is based on classifications from official government regulatory documents, which categorize potential adverse reactions by frequency and the body system affected. Since the medicine is for local application, the safety profile is primarily focused on oromucosal effects.

Adverse Reaction Frequency and System Groupings

The following are examples of adverse reactions listed in regulatory documents, grouped by their official frequency classification:

Frequency Classification Associated Adverse Reactions Affected System-Organ Class
Common Disturbance of taste (Dysgeusia); Burning sensation on the tongue. Nervous / Gastrointestinal
Uncommon Discoloration or staining of the teeth, tongue, or dental restorations. Gastrointestinal
Not Known Severe hypersensitivity reactions, Angioedema, Anaphylactic shock. Immune System

Serious Adverse Reactions and Safety Patterns

The most clinically significant adverse reactions officially documented are Anaphylactic shock and Angioedema, which are rare, severe generalized allergic reactions associated with the active ingredient Chlorhexidine. These serious immune system reactions are categorized as having a frequency that cannot be estimated from the available data.

Time-related safety patterns indicate that staining and an increase in calculus (tartar) formation are typically associated with prolonged or continuous use. Conversely, local irritation and the burning sensation on the tongue are often reported to occur upon initial use and may diminish with continued application.

Official regulatory restrictions state that the solution is for oral use only and must not be swallowed. Additionally, the product is contraindicated in individuals with a known hypersensitivity to any of the active ingredients or excipients.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for this product defines overdose concerns primarily through two distinct emergency scenarios: the risk of severe hypersensitivity events and potential systemic effects following accidental ingestion of a large volume.

When to Seek Immediate Medical Attention

Immediate medical attention must be sought for any signs of a life-threatening allergic reaction associated with the active ingredient. These severe manifestations include the sudden onset of difficulty breathing, swelling of the face, or a rapidly spreading severe rash.

Manifestations of Accidental Ingestion

Accidental oral ingestion of a large volume may lead to systemic effects. The officially documented clinical presentations include signs of neurological toxicity and gastric distress, such as nausea. Owing to the product’s alcoholic base, ingestion can also cause signs consistent with acute alcohol intoxication.

Management for significant ingestion is defined as requiring symptomatic and supportive treatment. If systemic passage occurs and neurological signs develop, treatment in a specialised environment is required. For the acute management of ingestion, gastric lavage may be considered advisable, potentially involving the use of demulcents.

Specific considerations exist for small children: if a volume greater than four ounces is consumed, or if any signs of alcohol intoxication appear, medical attention is mandatory.

Therapeutic Uses of EludrilPro

What EludrilPro Treats: Main Uses and Benefits

EludrilPro is primarily intended to manage symptoms associated with various oral health issues. The solution is used to support patient comfort, particularly when experiencing discomfort or inflammation in the mouth and throat. This medication is not a treatment for the underlying disease but serves as an aid in overall oral care.

Common clinical scenarios where this solution is used include temporary relief of symptoms associated with oral inflammation, as an aid in oral care related to gum conditions, and use after minor dental or oral procedures. The intended benefit is to promote a clean oral environment and assist in the maintenance of patient comfort.

Quick Fact: Provides support for Symptomatic Oral Discomfort

Eligibility and Restrictions for Use

Eligibility for EludrilPro Use

The eligibility profile for EludrilPro is strictly defined by regulatory documentation, establishing which population groups may use the product and which are prohibited or restricted.

Absolute Contraindications

Use of the medicine is contraindicated and must be avoided by individuals with a known hypersensitivity or allergy to the active ingredients, Chlorhexidine Gluconate or Chlorobutanol, or any of the inactive excipients, such as Cochineal red A.

Age-Group Eligibility

The solution is reserved for adults and children over 6 years of age. Use is prohibited in pediatric patients under the age of six years.

Conditional and Restricted Use

Use during pregnancy is restricted and should occur only if clearly needed, necessitating prior professional consultation. For nursing mothers, caution is advised as it is not conclusively known whether the drug is excreted into human milk. Regulatory data also indicate that use is not fully established in the geriatric population due to insufficient clinical study data in subjects aged 65 and over. No specific restrictions are documented for patients with hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for EludrilPro focuses primarily on local interactions resulting from the product’s oromucosal application. Since the active ingredients (Chlorhexidine Gluconate and Chlorobutanol) exhibit minimal systemic absorption, the medicine's official profile lacks documented systemic pharmacokinetic interactions, such as those involving CYP enzymes or drug transporters.

Documented Interaction Profile

Category Official Regulatory Statement
Interacting Product Category Other local Oromucosal Antiseptics and agents.
Mechanistic Basis (Label Statement) Local interference leading to antagonism or inactivation.
Timing-based Restriction Simultaneous or successive use of other local antiseptics must be avoided.
Food/Systemic Interaction Note Interactions with Food and Drink and Herbal products are officially noted as Not Applicable.

The core interaction restriction mandates the separation of administration from other local antiseptic solutions. Co-administration carries the documented risk of antagonism or inactivation, which formally reduces the local concentration and intended efficacy of the active ingredients. This restriction is essential for maintaining the product's intended function. No specific drug or substance is formally designated as contraindicated due to a drug-drug interaction mechanism.

Mechanism of Action

How EludrilPro Works

EludrilPro contains the active components chlorhexidine digluconate and chlorobutanol hemihydrate, which exert localized pharmacodynamic effects on cellular components and microbial function within the oral environment.

Membrane-Targeted Microbial Regulation

The primary agent, chlorhexidine, acts as a cationic molecule that engages microbial cells, primarily bacteria. Its positive charge targets the negatively charged surface of the cell membrane, initiating disruption and destabilization of the lipid bilayer structure. This mechanistic cascade increases membrane permeability, allowing the substance to penetrate the cell. The subsequent coagulation of intracellular components—including nucleic acids and proteins—results in the inhibition of microbial replication and growth.

Non-Specific Cellular and Microbial Modulation

Chlorobutanol contributes to the overall action by engaging a secondary, non-specific mechanism against various microorganisms, including certain bacteria and fungi. This substance interacts with cellular structures to modify local physiological processes influenced by microbial components, thereby complementing the primary membrane-targeted effects of chlorhexidine. This concurrent mechanism aids in achieving localized modification of the microbial environment.

Dosage and Administration Information

How to Use EludrilPro

The usage of EludrilPro is a topical oromucosal application. This solution is specifically intended for local use as a mouthwash and must not be swallowed. The administration is characterized by a mandated dilution and a defined course duration.

Administration Protocol

Usage Entity Instruction
Route of Administration Oromucosal (Mouthwash only)
Age Restriction Reserved for adults and children over 6 years of age
Frequency Pattern Typically Twice Daily (maximum of three times daily)
Course Duration Limited to two weeks, unless explicitly extended by medical advice

Dosing and Preparation Requirements

Dosing specifies the use of 10 mL to 15 mL of the concentrated solution per application, with a maximum daily volume of 20 mL. Dilution is mandatory: the measured concentrate must be mixed with lukewarm water to the designated fill line of the measuring cup before use. The procedural sequence requires that users brush their teeth and rinse their mouth thoroughly with water prior to administering the diluted solution. This is followed by rinsing the mouth for approximately one minute, then spitting out the solution.

These instructions define a standardized protocol for use, focusing strictly on volume, preparation, frequency, and local administration.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Clinical research has focused on the components of EludrilPro—chlorhexidine digluconate and chlorobutanol hemihydrate—to investigate their effects in oral health maintenance and post-operative care.

Studies on Chlorhexidine (CHX)

Systematic reviews and randomized controlled trials (RCTs) primarily investigate chlorhexidine's role as an adjunct to mechanical oral hygiene procedures. Evidence consistently indicates that chlorhexidine-containing mouthrinses, when used short-term (e.g., 4 to 6 weeks), lead to a large reduction in dental plaque accumulation.

  • Gingivitis: Clinical trials have observed a moderate reduction in gingivitis (gum inflammation), particularly in individuals presenting with mild inflammation. Its anti-plaque effect is generally more pronounced than its effect on reducing gingival index scores.
  • Dental Surgery: Studies have also examined the use of CHX mouthrinses following dental extractions, such as third molar removal. This research investigates whether it alters the risk of post-operative complications like alveolar osteitis (dry socket).

Studies on Chlorobutanol (CBL)

Chlorobutanol is frequently included in oral and dental formulations. Clinical research involving chlorobutanol has examined its use alongside chlorhexidine and other agents in various dental procedures.

  • Post-operative Comfort: In combination with other components, chlorobutanol has been evaluated in the context of post-extraction complications, where it is often studied for its properties that may influence pain perception and discomfort following surgery.
  • Antimicrobial Activity: Laboratory studies have investigated the antimicrobial and antifungal properties of the chlorhexidine-chlorobutanol combination, suggesting the combination exhibits strong activity against common oral microbial strains.

Key Studies & References Systematic review and meta-analysis of the efficacy of chlorhexidine mouthrinses in reducing alveolar osteitis (dry socket) following third molar extraction

How should EludrilPro be stored and disposed of?

Storage and Disposal of EludrilPro: Official Regulatory Instructions

Storage and disposal requirements for EludrilPro mouthwash are defined by official regulatory labeling to ensure product stability and environmental safety.

Storage Conditions

  • General Requirements: The medicine does not require any special storage conditions concerning temperature or the environment for the unopened bottle.
  • Child Safety: It is a mandatory instruction to keep EludrilPro out of the sight and reach of children.
  • Time-Based Stability: The solution must be discarded 14 days after opening the bottle, and must not be used beyond the expiry date printed on the container.

Disposal Requirements

To prevent environmental contamination, unused or expired EludrilPro must not be disposed of via wastewater or household waste. Patients are instructed to ask a pharmacist for the correct procedure on how to dispose of medicines that are no longer required.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagFrance

Equivalent of EludrilPro found in:

A-Z Index: